Tombot creates pets for people who can’t have pets. Tombot was launched in 2017 to serve the 4 billion people that don’t keep live animals as pets for reasons including health adversity, cost, burden of care, and living restrictions.

Voted Best Product at CES 2025 by the Tech Podcast Network

Animatronic artistry by Jim Henson's Creature Shop (creator of The Muppets)

Scientifically engineered to treat symptoms of mental illness

Aims to be the first robotic animal FDA device/health monitoring platform

A TIME Magazine "Best Invention" of 2020

1 billion people worldwide with serious mental health adversities

Initial clinical and marketing focus: older persons with dementia

Go To Market: Dementia

Millions of dementia patients are depressed, in pain, and dangerously medicated

Of the 55 million people worldwide with dementia, most suffer from loneliness, apathy, depression, hallucinations and/or chronic pain. Doctors frequently prescribe psychotropic and opioid medications, but severe side effects reduce quality of life and increase risk of death.

For most, opioids and psychotropic drugs are the only available treatments.

97% of Seniors with Dementia suffer from behavioral and psychological symptoms¹

83% of nursing home residents have Chronic Pain²

Animal companionship has been shown to improve quality of life for nursing home residents and elders with dementia, but many seniors are unable to care for a live animal.

Meet Jennie

Voice Commands

Rechargeable

Interactive Sensors

Real Puppy Sounds

Software Updates

Tombot’s high-tech therapy robot Jennie is a masterful combination of art, science, and engineering. Engaging with Jennie provides joy, comfort, companionship, and a sense of security in the midst of destabilizing illness. Jennie is designed to alleviate the behavioral and psychological symptoms of dementia, including Sundowning Syndrome—a state of confusion common in dementia patients.

Rather than the repetitive, programmed behavior seen in theme park animatronics, Jennie is uniquely interactive and autonomous, with patent-pending behaviors that mimic a real puppy.

Tombot anticipates our patent-protected puppies will be the first to be FDA medical devices, ultimately attaining public and private health insurance reimbursements.

Big Opportunity

4 billion people do not keep live animals as pets

Strong Team

Relevant domain expertise with track record of success

Institutional Investors

Leads: Caduceus Capital Partners Wavemaker 360 Health

Opportunity

Sustainable Differentiators

IP granted and regulatory protection

Customer Traction

20,000+ pre-order and waitlist customers from 116 countries

Tombot occasionally seeks funds from institutional and accredited investors to fund our mission to transform the lives of the more than one billion people worldwide facing serious health adversities. For more information, please scroll down and click on the “ACCREDITED INVESTORS” button."

Jennie has caught the eye of several prominent institutional investors, and we’ve already raised significant funds from VCs, family offices, angels, and a corporate VC.

*15M raised as of Summer 2025

Go To Market: Dementia